https://jcto.weill.cornell.edu/daily1.0 https://jcto.weill.cornell.edu/about2022-06-17T16:28Znever https://jcto.weill.cornell.edu/node/121842017-05-19T14:02Znever https://jcto.weill.cornell.edu/open_clinical_trials/pilot-study-to-collect-blood-from-research-subjects-allergic-and-non-allergic-to-peanut-to-study-immune-modulation-with-anti-ige-therapy-in-mice2024-01-23T14:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-multi-center-african-american-ibd-study-maais2022-12-30T15:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-national-prospective-study-of-pregnancy-and-neonatal-outcomes-in-women-with-inflammatory-bowel-disease2022-12-30T15:21Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-safety-study-of-unlicensed-investigational-cryopreserved-cord-blood-units-cbus-manufactured-by-the-national-cord-blood-program-ncbp-and-provided-for-unrelated-hematopoietic-stem-cell-transplantation-of-pediatric-and2023-03-15T17:04Znever https://jcto.weill.cornell.edu/news/the-transporter2015-09-29T22:34Znever https://jcto.weill.cornell.edu/news/weill-cornell-medical-college-and-newyork-presbyterian-hospital-license-technology-to-lumendi-ltd2015-09-22T16:57Znever https://jcto.weill.cornell.edu/news/gift-names-caryl-and-israel-englander-institute-for-precision-medicine2015-09-22T17:00Znever https://jcto.weill.cornell.edu/news/how-patients-can-benefit-from-clinical-trials2015-09-22T17:09Znever https://jcto.weill.cornell.edu/news/weill-cornell-medical-college-and-newyork-presbyterian-hospital-to-introduce-electronic-informed-consent-into-its-cancer-clinics2016-03-29T13:55Znever https://jcto.weill.cornell.edu/news/food-order-has-significant-impact-on-glucose-and-insulin-levels2015-09-29T22:36Znever https://jcto.weill.cornell.edu/news/weill-cornell-researchers-improve-risk-assessment-for-stable-patients-with-suspected-heart-disease2015-09-29T21:51Znever https://jcto.weill.cornell.edu/news/bacterial-endocarditis-increases-stroke-risk-for-longer-period-than-previously-reported2015-09-29T22:35Znever https://jcto.weill.cornell.edu/news/improving-the-odds-for-people-with-non-hodgkin-lymphoma2015-09-29T22:35Znever https://jcto.weill.cornell.edu/news/weill-cornell-investigators-discover-how-ovarian-cancer-halts-bodys-natural-defense-against-tumor2015-09-29T21:49Znever https://jcto.weill.cornell.edu/news/new-weill-cornell-medicine-name-announced2015-10-19T17:21Znever https://jcto.weill.cornell.edu/news/landmark-study-investigates-substance-use-and-adolescent-brain-development2015-10-19T17:20Znever https://jcto.weill.cornell.edu/news/new-scientific-director-at-richard-t-silver-md-myeloproliferative-neoplasm-center2015-10-20T17:35Znever https://jcto.weill.cornell.edu/news/a-guide-for-the-health-care-system2015-10-22T19:36Znever https://jcto.weill.cornell.edu/news/skinny-fat2015-10-29T16:32Znever https://jcto.weill.cornell.edu/news/study-of-breast-cancer-metastasis-upends-conventional-wisdom-suggesting-new-treatment-strategy2015-11-17T15:01Znever https://jcto.weill.cornell.edu/news/the-librarys-new-open-acess-3d-printer-gets-rave-review2015-11-25T16:28Znever https://jcto.weill.cornell.edu/news/for-decades-weill-cornell-has-been-a-leader-in-the-research-revolution-thats-making-lymphoma-a-survivable-disease2025-06-13T17:56Zyearly https://jcto.weill.cornell.edu/news/the-anxiety-gene2016-01-15T20:56Znever https://jcto.weill.cornell.edu/news/dr-lewis-c-cantley-wins-wolf-prize-in-medicine2016-01-19T21:52Znever https://jcto.weill.cornell.edu/news/fungus-fighter2016-01-27T17:57Znever https://jcto.weill.cornell.edu/news/the-real-moonshot-for-cancer2016-01-27T18:18Znever https://jcto.weill.cornell.edu/news/womens-studies2016-01-27T18:25Znever https://jcto.weill.cornell.edu/news/newyork-presbyterian-columbia-university-medical-center-and-weill-cornell-medicine-among-the-nations-cancer-centers-endorsing-hpv-vaccination-for-cancer-prevention2016-01-29T21:36Znever https://jcto.weill.cornell.edu/news/haitian-aids-patients-10-year-survival-equal-to-american-patients2016-01-29T21:38Znever https://jcto.weill.cornell.edu/news/from-foe-to-friend-transforming-tumors-into-personalized-vaccines2025-06-13T18:02Zyearly https://jcto.weill.cornell.edu/news/weill-cornell-physician-scientists-and-cornell-university-engineers-collaborate-—-and-patients-benefit2016-02-07T02:32Znever https://jcto.weill.cornell.edu/news/experimental-therapy-could-treat-diabetes-and-fatty-liver2016-02-07T02:36Znever https://jcto.weill.cornell.edu/news/among-keys-to-curing-cancer-academic-medical-centers-loom-large2016-02-16T14:32Znever https://jcto.weill.cornell.edu/news/heres-how-virtual-reality-could-help-doctors-treat-cancer2016-03-08T17:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/gene-expression-monitoring-of-renal-allograft-status-gem-tissue2023-03-15T19:11Znever https://jcto.weill.cornell.edu/open_clinical_trials/development-of-gene-expression-monitoring-gem-bio-bank-to-study-non-invasive-bio-markers-that-diagnose-and-anticipate-post-transplant-complications2023-03-15T19:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/repository-of-novel-analytes-leading-to-autoimmune-inflammatory-and-diabetic-nephropathies-renal-aid2022-12-30T15:00Znever https://jcto.weill.cornell.edu/about/careers2023-11-15T21:44Znever https://jcto.weill.cornell.edu/news/excessive-iron-in-the-lung-implicated-in-copd2016-03-29T13:51Znever https://jcto.weill.cornell.edu/news/a-married-pair-of-social-scientists-promotes-compassionate-care-for-cancer-patients-at-the-end-of-life-and-the-loved-ones-they-leave-behind2025-06-13T18:00Zyearly https://jcto.weill.cornell.edu/news/weill-cornell-lymphoma-program-study-on-mantle-cell-lymphoma-has-received-a-top-10-clinical-research-forum-achievement-award-from-a-national-clinical-research-organization2016-04-14T18:59Znever https://jcto.weill.cornell.edu/news/interim-dean-to-lead-weill-cornell-medicine-beginning-june-12016-04-19T13:52Znever https://jcto.weill.cornell.edu/news/jill-roberts-institute-for-research-in-inflammatory-bowel-disease-leads-the-field2016-08-09T17:16Znever https://jcto.weill.cornell.edu/news/what-inspires-giving-meet-dr-john-leonard2022-05-20T14:39Znever https://jcto.weill.cornell.edu/open_clinical_trials/autosomal-dominant-polycystic-kidney-disease-data-repository2022-12-30T14:58Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-rogosin-institute-homozygous-familial-hypercholesterolemia-repository2022-12-30T14:58Znever https://jcto.weill.cornell.edu/news/newyork-presbyterian-weill-cornell-medicine-and-columbia-university-college-of-physicians-and-surgeons-join-launch-of-spark-nations-largest-autism-research-study2016-04-29T16:51Znever https://jcto.weill.cornell.edu/news/cardiovascular-research-institute-established-at-weill-cornell-medicine2016-05-02T15:14Znever https://jcto.weill.cornell.edu/news/study-describes-potential-transmission-of-non-genetic-behavioral-traits-to-new-generations2016-05-13T14:39Znever https://jcto.weill.cornell.edu/news/inside-medicine-bench-to-bedside2016-05-13T14:41Znever https://jcto.weill.cornell.edu/news/erica-home-is-where-the-heart-is2016-05-25T15:01Znever https://jcto.weill.cornell.edu/news/mathematical-analysis-of-drug-resistance-in-chronic-leukemia2016-05-25T15:09Znever https://jcto.weill.cornell.edu/news/dr-david-e-cohen-named-chief-of-division-of-gastroenterology-and-hepatology-at-weill-cornell-medicine-and-newyork-presbyterianweill-cornell-medical-center2016-06-28T13:48Znever https://jcto.weill.cornell.edu/news/innovative-immunotherapy-more-effective-in-treating-an-aggressive-lymphoma-than-chemotherapy2025-06-09T15:22Zyearly https://jcto.weill.cornell.edu/news/scientists-propose-a-framework-for-more-comprehensive-assessment-of-medical-device-safety-and-efficacy2016-06-28T13:52Znever https://jcto.weill.cornell.edu/news/the-leukemia-lymphoma-society-names-john-p-leonard-md-of-weill-cornell-medicine-and-newyork-presbyterian-its-2016-manhattan-light-the-night-corporate-chair2016-06-28T21:06Znever https://jcto.weill.cornell.edu/news/new-gene-therapy-protects-against-peanut-allergy2025-06-13T18:06Zyearly https://jcto.weill.cornell.edu/news/not-just-a-shot-in-the-dark2016-07-12T17:24Znever https://jcto.weill.cornell.edu/news/four-nyc-medical-centers-receive-new-nih-precision-medicine-grant2025-06-13T18:01Zyearly https://jcto.weill.cornell.edu/news/we-are-weill-cornell-medicine-new-campaign-celebrates-accomplished-collaborative-community2016-07-19T15:09Znever https://jcto.weill.cornell.edu/news/anti-cocaine-vaccine-approved-for-clinical-study-in-people2016-08-08T19:43Znever https://jcto.weill.cornell.edu/news/damon-runyon-cancer-research-foundation-awards-prestigious-clinical-investigator-award-to-two-weill-cornell-medicine-scientists2016-08-08T19:59Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-pilot-study-of-ketogenic-diet-and-metformin-in-glioblastoma-feasibility-and-metabolic-imaging2022-12-30T14:51Znever https://jcto.weill.cornell.edu/news/1m-nih-grant-helps-researchers-refine-quick-cancer-test2016-08-31T16:27Znever https://jcto.weill.cornell.edu/news/former-detective-set-to-become-investigator-of-a-different-kind-a-scientist2016-08-31T16:30Znever https://jcto.weill.cornell.edu/news/grant-launches-center-on-the-physics-of-cancer-metabolism2025-06-13T18:04Zyearly https://jcto.weill.cornell.edu/news/why-is-a-clinical-trial-so-important2022-05-20T14:38Znever https://jcto.weill.cornell.edu/news/new-big-data-approach-predicts-drug-toxicity-in-humans2016-09-16T18:55Znever https://jcto.weill.cornell.edu/news/tall-order2016-09-16T18:57Znever https://jcto.weill.cornell.edu/news/we-are-weill-cornell-medicine-dr-olivier-elemento2016-09-23T19:14Znever https://jcto.weill.cornell.edu/news/researchers-develop-method-to-identify-patient-specific-drugs-for-treating-diabetes2016-09-23T19:16Znever https://jcto.weill.cornell.edu/news/theres-an-app-for-that2016-09-23T19:18Znever https://jcto.weill.cornell.edu/news/remission-without-admission2022-05-20T14:38Znever https://jcto.weill.cornell.edu/open_clinical_trials/carotid-revascularization-and-medical-management-for-asymptomatic-carotid-stenosis-trial-crest-22022-12-30T14:50Znever https://jcto.weill.cornell.edu/open_clinical_trials/research-registry-idiopathic-pulmonary-fibrosis-prospective-outcomes-registry-ipf-pro2022-12-30T14:25Znever https://jcto.weill.cornell.edu/open_clinical_trials/pediatric-inflammatory-bowel-disease-ibd-biobank2022-12-30T14:24Znever https://jcto.weill.cornell.edu/open_clinical_trials/imaging-and-pathologic-correlates-for-men-at-risk-of-prostate-cancer2022-12-30T14:19Znever https://jcto.weill.cornell.edu/node/132282017-04-14T18:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/characterization-of-the-microbiome-to-predict-complications-in-chronic-kidney-disease-and-end-stage-kidney-disease-patients2023-03-14T20:45Znever https://jcto.weill.cornell.edu/open_clinical_trials/bp1001-in-combination-with-low-dose-cytarabine-ldac-in-patients-with-previously-untreated-aml-who-are-ineligible-for-induction-therapy2022-12-29T17:23Znever https://jcto.weill.cornell.edu/news/understanding-clinical-trials-and-how-they-work2023-04-20T15:56Znever https://jcto.weill.cornell.edu/node/133922017-07-10T16:08Znever https://jcto.weill.cornell.edu/node/133932017-07-17T19:36Znever https://jcto.weill.cornell.edu/node/133942017-07-10T16:08Znever https://jcto.weill.cornell.edu/node/133952017-07-10T16:17Znever https://jcto.weill.cornell.edu/node/133962017-07-10T21:11Znever https://jcto.weill.cornell.edu/node/133972017-07-12T19:48Znever https://jcto.weill.cornell.edu/node/133982017-07-10T21:16Znever https://jcto.weill.cornell.edu/node/133992017-07-10T19:46Znever https://jcto.weill.cornell.edu/node/134002017-07-10T20:34Znever https://jcto.weill.cornell.edu/node/134012017-07-10T20:43Znever https://jcto.weill.cornell.edu/node/134022017-07-10T20:54Znever https://jcto.weill.cornell.edu/open_clinical_trials/safety-of-immunosuppression-in-a-prospective-cohort-of-inflammatory-bowel-disease-patients-with-a-history-of-cancer-sapphire2022-12-29T17:08Znever https://jcto.weill.cornell.edu/search/clinical-trials2019-03-18T21:02Znever https://jcto.weill.cornell.edu/open_clinical_trials/comprehensive-care-in-patients-with-thalassemia-and-severe-congenital-anemias2022-12-29T17:04Znever https://jcto.weill.cornell.edu/open_clinical_trials/roma-trial2022-12-29T17:00Znever https://jcto.weill.cornell.edu/patients/clinical-trials-common-terms-to-know2018-11-28T20:06Znever https://jcto.weill.cornell.edu/patients/clinical-trial-questions-to-ask-your-healthcare-team2018-11-28T20:06Znever https://jcto.weill.cornell.edu/open_clinical_trials/clonevo-cell-cycle-inhbition-to-target-the-evolution-of-urothelial-cancer2024-10-08T17:41Znever https://jcto.weill.cornell.edu/open_clinical_trials/fecal-microbiota-transplantation-national-registry2023-11-07T16:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/ironman-international-registry-for-men-with-advanced-prostate-cancer2024-12-27T16:10Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-gene-transfer-open-label-dose-escalation-study-of-spk-8011-recombinant-adeno-associated-viral-vector-with-b-domain-deleted-human-factor-viii-gene-in-individuals-with-hemophilia-a2022-12-29T16:21Znever https://jcto.weill.cornell.edu/open_clinical_trials/target–nash-a-5-year-longitudinal-observational-study-of-patients-with-non-alcoholic-fatty-liver-or-non-alcoholic-steatohepatitis2023-11-07T16:54Znever https://jcto.weill.cornell.edu/open_clinical_trials/advanced-endoscopic-therapies-aets-a-retrospective-and-prospective-multicenter-registry2022-12-29T16:14Znever https://jcto.weill.cornell.edu/about/partner-with-the-jcto/jcto-fees2024-03-08T16:22Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-study-with-an-expansion-cohortrandomized-phase-2-study-of-the-combinations-of-ipilimumab-nivolumab-and-brentuximab-vedotin-in-patients-with-relapsedrefractory-hodgkin-lymphoma2022-12-29T16:06Znever https://jcto.weill.cornell.edu/about/our-clinical-trial-locations2019-03-21T19:39Znever https://jcto.weill.cornell.edu/open_clinical_trials/aro-021-phase-iii-randomized-study-of-crenolanib-versus-midostaurin-administered-following-induction-chemotherapy-and-consolidation-therapy-in-newly-diagnosed-subjects-with-flt3-mutated-acute-myeloid-leukemia2022-12-29T16:04Znever https://jcto.weill.cornell.edu/cwid-required2021-02-23T16:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/long-term-outcomes-of-obese-patients-with-gastrointestinal-complications-of-disease2023-11-07T16:54Znever https://jcto.weill.cornell.edu/open_clinical_trials/pembrolizumab-and-stereotactic-radio-surgery-srs-of-selected-brain-metastases-in-breast-cancer-patients2022-12-29T16:03Znever https://jcto.weill.cornell.edu/open_clinical_trials/agct1532-phase-3-accelerated-bep-trial-a-randomized-phase-3-trial-of-accelerated-vs-standard-bep-chemotherapy-for-patients-with-intermediate-and-poor-risk-metastatic-germ-cell-tumors2023-02-15T15:21Znever https://jcto.weill.cornell.edu/open_clinical_trials/dora-trial-phase-3-trial-of-docetaxel-vs-docetaxel-and-radium-223-for-metastatic-castration-resistant-prostate-cancer-mcrpc2022-12-29T15:59Znever https://jcto.weill.cornell.edu/open_clinical_trials/brain-function-emotions-and-behavior-in-healthy-older-adults2022-12-29T15:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/positive-valence-system-function-and-reward-exposure-therapy-for-late-life-depression2022-12-29T15:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/efficacy-of-biomarker-guided-rtms-for-treatment-resistant-depression2023-09-05T15:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-non-inferiority-randomized-controlled-clinical-trial-comparing-interpersonal-therapy-to-exposure-therapy-for-ptsd-consequent-to-military-sexual-trauma-mst-in-male-and-female-military-personnel-and-veterans2023-11-27T20:51Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-comprehensive-psychological-intervention-to-improve-community-and-vocational-reintegration-following-burn-injury-and-other-trauma2022-12-29T15:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/virtual-reality-for-pain-management-in-burn-patients2019-07-19T19:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/assessment-of-physiological-reactions-associated-with-post-traumatic-stress-disorder-due-to-military-sexual-trauma-in-female-service-members2022-12-29T15:49Znever https://jcto.weill.cornell.edu/open_clinical_trials/problem-adaptation-therapy-for-mild-cognitive-impairment-and-depression-02022-12-29T15:48Znever https://jcto.weill.cornell.edu/open_clinical_trials/understanding-the-dynamic-interactions-between-tau-pathology-and-microgliamediated-inflammation-in-alzheimers-disease2024-05-24T14:42Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/converting-hr-breast-cancer-into-an-individualized-vaccine2022-12-28T19:30Znever https://jcto.weill.cornell.edu/open_clinical_trials/mri-detection-of-carotid-plaques-as-a-mechanism-for-embolic-strokes-of-undetermined-source-mri-decipher2022-12-28T19:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/biochemical-characterization-of-parkinsons-disease-related-proteins-in-the-enteric-nervous-system2024-05-24T14:52Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/anticoagulation-in-intracerebral-hemorrhage-ich-survivors-for-stroke-prevention-and-recovery-aspire2022-12-28T19:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/identifying-mechanisms-of-tissues-injury-in-ms-lesions-a-multi-modality-imaging-approach2022-12-28T19:19Znever https://jcto.weill.cornell.edu/open_clinical_trials/utilizing-smartphone-applications-in-parkinsons-disease-management2022-12-28T18:43Znever https://jcto.weill.cornell.edu/open_clinical_trials/perimenopause-and-brain-aging-in-alzheimers-disease2022-12-28T18:42Znever https://jcto.weill.cornell.edu/open_clinical_trials/statins-use-in-intracerebral-hemorrhage-patients-saturn2022-12-28T18:41Znever https://jcto.weill.cornell.edu/open_clinical_trials/glucocorticoid-receptor-antagonism-in-the-treatment-of-cushing-syndrome-grace-a-phase-3-double-blind-placebo-controlled-randomized-withdrawal-study-of-the-efficacy-and-safety-of-relacorilant2022-12-28T18:41Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-i-first-in-human-multicenter-open-label-study-of-nous-209-genetic-vaccine-for-the-treatment-of-microsatellite-unstable-solid-tumors2023-03-20T13:51Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-nyph-weill-cornell-medical-center-gastrointestinal-oncology-registry2022-12-28T18:39Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-lucinda-trial2022-12-28T18:38Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-comprehensive-set-of-data-to-be-utilized-for-future-projects-of-those-patients-that-will-be-undergoing-a-stem-cell-transplant-at-the-wcmcnyph2023-03-15T16:50Znever https://jcto.weill.cornell.edu/open_clinical_trials/indications-for-use-of-cd34-selection-column-clinimacs-miltenyi-biotec2023-03-15T16:46Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multi-center-access-and-distribution-protocol-for-unlicensed-cryopreserved-cord-blood-units-cbus-for-transplantation-in-pediatric-and-adults-patients-with-hematologic-malignancies-and-other-indications2023-03-15T16:45Znever https://jcto.weill.cornell.edu/open_clinical_trials/protocol-for-a-research-sample-repository-for-allogeneic-hematopoietic-stem-cell-transplantation-other-cellular-therapies-and-marrow-toxic-injuries2022-12-28T18:31Znever https://jcto.weill.cornell.edu/open_clinical_trials/national-marrow-donor-program-nmdp-and-center-for-international-blood-and-marrow-transplant-research-cibmtr-–-research-database-for-hematopoietic-stem-cell-transplantation-other-cellular-therapies-and-marrow-toxic-injuries2022-12-28T18:31Znever https://jcto.weill.cornell.edu/open_clinical_trials/experiences-perceptions-and-needs-of-critical-care-fellows-during-the-covid-19-pandemic2023-03-15T16:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/immunotherapy-with-nivolumab-and-ipilimumab-followed-by-nivolumab-or-nivolumab-with-cabozantinib-for-patients-with-advanced-kidney-cancer-the-pdigree-study2025-06-10T15:05Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-iii-dose-escalation-study-of-fractionated-and-multiple-dose-225ac-j591-for-progressive-metastatic-castration-resistant-prostate-cancer2024-05-24T14:59Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/early-identification-and-treatment-of-occult-metastatic-disease-in-stage-iii-colon-cancer2023-01-18T14:07Znever https://jcto.weill.cornell.edu/lucinda2024-10-22T15:44Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/single-arm-phase-ii-study-of-psma-petmr-guided-stereotactic-body-radiation-therapy-with-simultaneous-integrated-boost-sbrt-sib-for-high-intermediate-and-high-risk-prostate-cancer2024-05-24T14:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-pilot-study-of-rimegepant-in-moderate-plaque-type-psoriasis2024-11-21T20:37Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/multimodal-neuroimaging-in-traumatic-brain-injury2025-12-01T16:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/daratumumab-pomalidomide-and-dexamethasone-dpd-in-relapsedrefractory-light-chain-amyloidosis-patients-previously-exposed-to-daratumumab2022-12-28T16:54Znever https://jcto.weill.cornell.edu/closed_trial2021-03-16T19:19Znever https://jcto.weill.cornell.edu/open_clinical_trials/vmo-01c-an-open-label-multiple-dose-dose-escalation-study-to-investigate-the-safety-pharmacokinetics-and-pharmacodynamics-of-vmd-928-in-subjects-with-solid-tumors-or-lymphoma2023-03-14T17:42Znever https://jcto.weill.cornell.edu/open_clinical_trials/csf-clearance-in-sporadic-alzheimer’s-disease2022-12-28T16:49Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-effects-of-iron-on-oxidative-stress-and-alzheimer’s-disease-biomarkers-in-amyloid-positive-and-negative-elderly-individuals2022-12-28T16:48Znever https://jcto.weill.cornell.edu/open_clinical_trials/treatment-of-newly-diagnosed-diffuse-anaplastic-wilms-tumors-dawt-and-relapsed-favorable-histology-wilms-tumors-fhwt2022-12-28T16:48Znever https://jcto.weill.cornell.edu/investigators/study-activation-and-conduct/esignature2025-02-28T15:22Zyearly https://jcto.weill.cornell.edu/investigators/training-and-education/training-video-library2021-06-29T20:28Znever https://jcto.weill.cornell.edu/open_clinical_trials/pragmatic-evaluation-of-events-and-benefits-of-lipid-lowering-in-older-adults-preventable2025-02-14T14:24Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-volixibat-in-the-treatment-of-cholestatic-pruritus-in-patients-with-primary-sclerosing-cholangitis-vistas2023-11-07T16:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/transoral-incisionless-fundoplication-tif-registry2026-03-09T15:52Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/accelerated-tms-for-depression-and-ocd2025-07-09T14:59Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-prospective-randomized-double-blind-sham-controlled-multi-center-pivotal-study-to-evaluate-the-efficacy-and-safety-of-duodenal-mucosal-resurfacing-using-the-revita-system-in-subjects-with-type-2-diabetes-on-insulin-therapy2023-11-07T16:56Znever https://jcto.weill.cornell.edu/patients/understanding-clinical-trials-in-spanish-en-español2021-09-20T15:23Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-effect-of-semaglutide-in-subjects-with-non-cirrhotic-non-alcoholic-steatohepatitis2024-07-30T19:29Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-trial-for-patients-with-de-novo-aml-comparing-standard-therapy-including-gemtuzumab-ozogamicin-go-to-cpx-351-with-go-and-the-addition-of-the-flt3-inhibitor-gilteritinib-for-patients-with-flt3-mutations2023-03-14T20:47Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-3-trial-of-nivolumab-in-combination-with-chemo-immunotherapy-for-the-treatment-of-newly-diagnosed-primary-mediastinal-b-cell-lymphoma2022-12-28T16:12Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-multicenter-study-of-incb000928-administered-as-a-monotherapy-or-in-combination-with-ruxolitinib-in-participants-with-anemia-due-to-myeloproliferative-disorders2022-12-28T16:11Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-trial-of-paxalisib-combined-with-a-ketogenic-diet-and-metformin-for-newly-diagnosed-and-recurrent-glioblastoma2022-12-28T16:09Znever https://jcto.weill.cornell.edu/open_clinical_trials/randomized-trial-of-five-or-two-mri-guided-adaptive-radiotherapy-treatments-for-prostate-cancer2022-12-28T15:48Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-study-to-test-the-efficacy-of-ab928-dual-adenosine-receptor-antagonist-and-ab122-a-pd1-checkpoint-inhibitor-in-combination-with-short-course-radiotherapy-and-consolidation-chemotherapy-for-rectal-cancer-panther2022-12-28T15:48Znever https://jcto.weill.cornell.edu/news/dr-mario-gaudino-awarded-grant-for-stich3c-study2022-05-20T14:38Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-study-of-daratumumab-clarithromycin-pomalidomide-and-dexamethasone-d-clapd-in-multiple-myeloma-patients-previously-exposed-to-daratumumab2023-04-06T20:51Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-phase-1-treatment-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-ide397-mat2a-inhibitor-in-adult-participants-with-advanced-solid-tumors2023-03-14T17:37Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b2-study-of-imgn632-as-monotherapy-or-combination-with-venetoclax-andor-azacitidine-for-patients-with-cd123-positive-acute-myeloid-leukemia-02022-12-28T15:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-1b2-open-label-multicenter-dose-optimization-clinical-study-of-safety-tolerability-pharmacokinetic-pharmacodynamic-profiles-of-cfi-400945-as-a-single-agent-or-in-combination-with-azacitidine-or-decitabine-in-patients-with-aml2022-12-28T15:38Znever https://jcto.weill.cornell.edu/news/clinical-trials-day-20222022-05-20T14:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/development-of-a-novel-web-based-social-reward-task-to-test-engagement-of-the-reward-system-in-mid-and-late-life-depression2025-05-16T13:17Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-multicenter-open-label-dose-escalation-and-dose-expansion-study-to-evaluate-the-safety-pharmacokinetics-and-anti-tumor-activity-of-arx517-in-subjects-with-advanced-solid-tumors-resistant-or-refractory-to-standard-therapies2022-12-28T15:19Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-study-evaluating-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-efficacy-of-chaperone-mediated-protein-degrader-rnk05047-in-subjects-with-advanced-solid-tumors-champ-12023-01-18T14:10Znever https://jcto.weill.cornell.edu/open_clinical_trials/intra-arterial-ia-chemotherapy-for-newly-diagnosed-residual-or-recurrent-atypical-choroid-plexus-papilloma-acpp-and-choroid-plexus-carcinoma-cpc-prior-to-second-look-surgery2025-02-03T21:08Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/engage-connect-a-novel-neuroscience-informed-streamlined-psychotherapy-for-postpartum-depression2024-05-24T15:03Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-digital-intervention-for-post-stroke-depression-and-executive-dysfunction2024-10-09T13:33Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/ssri-impact-on-sperm-quality-a-randomized-placebo-controlled-trial2024-05-24T14:51Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/pharmacokinetic-evaluation-of-serum-testosterone-concentrations-after-administration-of-clomiphene-citrate2024-05-24T14:51Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/tissue-collection-for-drug-screening-and-bioanalysis2025-02-03T21:08Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iib-study-of-bp1002-a-liposomal-bcl-2-antisense-oligodeoxynucleotide-in-patients-with-refractoryrelapsed-acute-myeloid-leukemia-aml2022-12-28T15:11Znever https://jcto.weill.cornell.edu/rimegepant2022-12-21T14:37Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ia-study-of-aavrh10hfxn-gene-therapy-for-the-cardiomyopathy-of-friedreich’s-ataxia2025-06-05T18:17Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12a-open-label-multicenter-nonrandomized-safety-and-anti-tumor-activity-study-of-imm-1-104-a-novel-oral-dual-mek12-inhibitor-in-participants-with-previously-treated-ras-mutated-advanced-or-metastatic-solid-tumors2023-02-16T19:02Znever https://jcto.weill.cornell.edu/open_clinical_trials/efficacy-of-targeted-app-based-cognitive-behavioral-therapy-for-anxiety-and-depression2026-03-27T15:42Zweekly https://jcto.weill.cornell.edu/open_clinical_trials/whole-food-plant-based-diet-wfpbd-to-control-weight-and-metabo-inflammation-in-overweightobese-men-with-prostate-cancer-receiving-androgen-deprivation-therapy-adt-a-multi-center-randomized-control-trial2023-06-27T17:47Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multi-arm-phase-1b-study-of-talquetamab-with-other-anticancer-therapies-in-participants-with-multiple-myeloma2023-03-28T18:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/novel-exploratory-study-to-test-combination-of-botensilimab-and-balstilimab-immunotherapy-in-patients-with-resectable-colorectal-cancer-nest-12023-03-30T13:10Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-double-blind-randomised-study-to-assess-switching-to-azd9833-a-next-generation-oral-serd-cdk46-inhibitor-palbociclib-or-abemaciclib-vs-continuing-aromatase-inhibitor-letrozole-or-anastrozole-cdk46-inhibitor-in-hrher22024-05-24T14:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-i-trial-of-tazemetostat-in-combination-with-venetoclax-in-patients-with-relapsedrefractory-non-hodgkin-lymphoma2023-03-30T13:26Znever https://jcto.weill.cornell.edu/open_clinical_trials/liver-cirrhosis-network-cohort-study2023-11-07T16:48Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-study-to-evaluate-the-efficacy-and-safety-of-pembrolizumab-mk-3475-lenvatinib-e7080mk-7902-chemotherapy-compared-with-standard-of-care-as-first-line-intervention-in-participants-with-metastatic-esophageal2023-04-06T20:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/open-label-phase-ii-trial-of-cabozantinib-in-patients-with-metastatic-castrate-resistant-prostate-cancer-mcrpc-and-known-amplifications-or-activating-mutations-in-gene-targets-of-cabozantinib-who-have-received-prior-anti-androgen2024-12-26T16:11Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-iii-trial-of-pembrolizumab-and-androgen-receptor-pathway-inhibitor-with-or-without-225ac-j591-for-progressive-metastatic-castration-resistant-prostate-cancer2025-02-21T14:31Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-iii-225ac-j591-plus-177lu-psma-it-for-progressive-metastatic-castration-resistant-prostate-cancer2023-04-06T21:06Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-multicenter-phase-12-study-of-rp1-as-a-single-agent-and-in-combination-with-pd1-blockade-in-patients-with-solid-tumors2023-04-06T21:14Znever https://jcto.weill.cornell.edu/open_clinical_trials/comparison-of-venipuncture-serum-prostate-specific-antigen-psa-with-point-of-care-fingerstick-blood-draw-rapid-test-for-psa-rt-psa2024-08-23T18:52Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/connect-myeloid-the-myelofibrosis-mf-myelodysplastic-syndromes-mds-and-acute-myeloid-leukemia-aml-disease-registry2023-04-07T17:30Znever https://jcto.weill.cornell.edu/open_clinical_trials/liquid-biopsy-for-longitudinal-monitoring-in-diffuse-midline-glioma-dmg-patients2025-01-17T15:39Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/next-generation-sequencing-to-evaluate-transcriptomic-changes-associated-with-h-pylori-infection-and-gastric-cancer-carcinogenesis2023-04-07T17:36Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-polatuzumab-vedotin-in-combination-with-chemotherapy-in-subjects-with-richter’s-transformation2023-04-07T18:33Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-first-in-human-dose-escalation-study-of-sar443579-administered-as-single-agent-by-intravenous-infusion-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-b-cell-acute-lymphoblastic-leukemia-or-high-risk2023-04-07T19:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/blood-coagulation-in-cancer-patients2023-04-11T14:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multiomics-profiling-study-to-classify-the-origin-of-cancers-of-unknown-primary-cup2023-04-11T15:00Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-open-label-randomized-2-part-study-comparing-gedatolisib-in-combination-with-palbociclib-fulvestrant-to-soc-therapies-in-patients-with-hr-her2-advanced-breast-cancer-previously-treated-with-a-cdk46-inhibitor-with-non2023-04-11T15:05Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-investigation-of-a-working-memory-training-program-for-neurological-surgery-patients-with-various-diagnoses2023-04-11T15:11Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b3-double-blind-randomized-active-controlled-3-stage-biomarker-adaptive-study-of-tazemetostat-or-placebo-in-combination-with-lenalidomide-plus-rituximab-in-subjects-with-relapsedrefractory-follicular-lymphoma2023-04-12T13:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-study-to-assess-the-anti-tumor-activity-and-safety-of-regn1979-an-anti-cd20-x-anti-cd3-bispecific-antibody-in-patients-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma2023-04-12T13:24Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-i-open-label-dose-escalation-and-dose-expansion-study-to-evaluate-the-safety-expansion-persistence-and-clinical-activity-of-ucart123-administered-in-patients-with-relapsedrefractory-aml-or-newly-diagnosed-high-risk-aml2023-04-12T20:18Znever https://jcto.weill.cornell.edu/open_clinical_trials/prognostic-significance-of-circulating-tumor-cells-in-prostate-cancer-a-pilot-study2023-04-26T13:26Znever https://jcto.weill.cornell.edu/open_clinical_trials/prospective-longitudinal-bio-specimen-collection-in-patients-with-early-breast-cancer-patients-who-receive-pre-operative-systemic-therapy-post-operative-adjuvant-systemic-therapy-and-metastatic-breast-cancer2023-04-26T13:30Znever https://jcto.weill.cornell.edu/node/152025-11-18T17:10Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-multicenter-double-blind-placebo-controlled-phase-2b-study-to-assess-the-safety-and-efficacy-of-igv-001-an-autologous-cell-immunotherapy-with-antisense-oligonucleotide-targeting-igf-1r-in-newly-diagnosed-patients-with2023-05-04T18:41Znever https://jcto.weill.cornell.edu/open_clinical_trials/zanubrutinib-and-venetoclax-as-initial-therapy-for-cll-with-obinutuzumab-consolidation-in-patients-with-minimal-residual-disease-positivity2023-05-04T19:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ib-randomized-phase-iii-trial-of-patients-with-advanced-hematologic-malignancies-undergoing-allogeneic-hematopoietic-cell-transplantation-with-either-orca-t-a-t-cell-depleted-graft-with-additional-infusion-of-conventional-t2023-05-10T15:27Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12a-open-label-dose-escalation-dose-expansion-parallel-assignment-study-to-evaluate-the-safety-and-clinical-activity-of-pbcar0191-in-subjects-with-relapsedrefractory-rr-non-hodgkin-lymphoma-nhl-and-rr-b-cell-acute2023-05-10T15:35Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-randomized-open-label-blinded-endpoint-evaluation-phase-3-study-comparing-the-effect-of-abelacimab-relative-to-dalteparin-on-venous-thromboembolism-vte-recurrence-and-bleeding-in-patients-with-gastrointestinal-gi2023-05-10T15:45Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-dose-escalation-and-expansion-study-of-the-bruton-tyrosine-kinase-targeted-protein-degrader-bgb-16673-in-patients-with-b-cell-malignancies2023-05-10T15:50Znever https://jcto.weill.cornell.edu/open_clinical_trials/multicenter-open-label-phase-3-study-of-tabelecleucel-for-solid-organ-or-allogeneic-hematopoietic-cell-transplant-subjects-with-epstein-barr-virus-associated-post-transplant-lymphoproliferative-disease-after-failure-of-rituximab-or2024-05-24T14:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-first-in-human-study-of-the-menin-mllkmt2a-inhibitor-ko-539-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia2023-05-10T16:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-wcm-advancing-hiv-health-through-epigenetic-studies-in-aging-and-alzheimers-disease-ahead-study2023-05-11T20:16Znever https://jcto.weill.cornell.edu/open_clinical_trials/feasibility-and-acceptability-of-a-mobile-cognitive-behavior-therapy-app-targeting-depression-and-anxiety-in-middle-aged-and-older-adults2026-03-27T15:42Zweekly https://jcto.weill.cornell.edu/open_clinical_trials/inflammatory-skin-disease-treatment-identification-study-identity2023-05-16T14:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/assessing-the-effect-of-abstinence-period-on-semen-analysis-parameters2024-05-24T14:50Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/ua-covid-19-national-registry-national-registry-of-pediatric-cancer-patients-diagnosed-with-covid-192023-05-23T15:26Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-olaparib-azd2281-in-patients-with-metastaticadvanced-urothelial-carcinoma-and-other-genitourinary-tumors-with-dna-repair-defects2024-08-23T18:52Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/pilot-study-of-ds-8201a-pharmacodynamics-in-patients-with-her2-expressing-advanced-solid-tumors2023-05-23T15:34Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-double-blind-randomised-placebo-controlled-international-study-to-assess-the-efficacy-and-safety-of-adjuvant-osimertinib-versus-placebo-in-participants-with-egfr-mutation-positive-stage-ia2-ia3-non-small-cell-lung-cancer2023-05-23T20:47Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-phase-ii-study-of-pomalidomide-monotherapy-in-kaposi-sarcoma2023-05-30T18:23Znever https://jcto.weill.cornell.edu/open_clinical_trials/colon-adjuvant-chemotherapy-based-on-evaluation-of-residual-disease-circulate-us2023-05-30T18:31Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-study-of-m3814-peposertib-in-combination-with-hypofractionated-radiotherapy-for-the-treatment-of-locally-advanced-pancreatic-adenocarcinoma2023-05-30T18:52Znever https://jcto.weill.cornell.edu/open_clinical_trials/randomized-phase-ii-study-of-choep-vs-cc-486-choep-vs-duvelisib-choep-in-previously-untreated-cd30-negative-peripheral-t-cell-lymphomas2023-05-30T20:57Znever https://jcto.weill.cornell.edu/open_clinical_trials/aaml18p1-stopping-tyrosine-kinase-inhibitors-tki-to-assess-treatment-free-remission-tfr-in-pediatric-chronic-myeloid-leukemia-chronic-phase-cml-cp2023-05-30T19:04Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-3-trial-of-vinorelbine-dactinomycin-and-cyclophosphamide-plus-maintenance-chemotherapy-with-vinorelbine-and-oral-cyclophosphamide-vino-cpo-vs-vincristine-dactinomycin-cyclophosphamide-plus-vino-cpo-maintenance-in-hr2023-05-30T19:09Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-cabozantinib-in-combination-with-nivolumab-and-ipilimumab-in-rare-genitourinary-tumors2023-05-30T19:35Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-dose-escalation-and-exploratory-dose-expansion-study-of-krt-232-amg-232-in-combination-with-carfilzomib-lenalidomide-and-dexamethasone-in-relapsed-andor-refractory-myeloma2023-06-16T15:58Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-open-label-phase-ii-trial-of-nab-paclitaxel-gemcitabine-with-or-without-botensilimab-agen1181-in-patients-with-metastatic-pancreatic-cancer-who-have-progressed-on-prior-5fu-leucovorin-irinotecan-oxaliplatin-folfirinox2025-06-30T14:55Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/the-pathfinder-2-study-evaluating-the-safety-and-performance-of-the-grail-multi-cancer-early-detection-test-in-an-eligible-screening-population-grail-0122024-01-29T15:05Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-multicenter-trial-of-iberdomide-as-maintenance-therapy-for-multiple-myeloma-patients-with-sub-optimal-response-after-autologous-hematopoietic-stem-cell-transplant-ahct2023-06-14T16:53Znever https://jcto.weill.cornell.edu/open_clinical_trials/c-800-25-a-randomized-open-label-phase-2-study-of-botensilimab-agen1181-as-monotherapy-and-in-combination-with-balstilimab-agen2034-for-the-treatment-of-advanced-refractory-microsatellite-stable-colorectal-cancer-without-liver2023-06-14T19:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/ultrasound-and-histologic-assessment-of-fat-in-the-breast-from-breast-cancer-patients2023-06-21T13:10Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iiia-theranostic-study-of-64cu-sar-bispsma-and-67cu-sar-bispsma-for-identification-and-treatment-of-psma-expressing-metastatic-castrate-resistant-prostate-cancer2023-07-12T16:58Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-3-interim-response-adapted-trial-comparing-standard-therapy-with-immuno-oncology-therapy-for-children-and-adults-with-newly-diagnosed-stage-i-and-ii-classic-hodgkin-lymphoma2023-08-01T19:25Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-i-open-label-dose-finding-study-of-tvb-2640-administered-in-combination-with-enzalutamide-xtandi-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc2023-07-14T16:15Znever https://jcto.weill.cornell.edu/open_clinical_trials/brain-changes-during-social-reward-psychotherapy-for-mid-and-late-life-suicidality-a-precision-imaging-trial2025-05-16T13:11Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/expanded-access-program-for-belantamab-mafodotin-in-patients-with-relapsedrefractory-multiple-myeloma-who-are-refractory-to-a-proteasome-inhibitor-and-an-immunomodulatory-agent-and-an-anti-cd38-antibody2024-05-31T17:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-dose-escalation-safety-pharmacokinetic-and-pharmacodynamic-study-of-oral-tp-3654-in-patients-with-intermediate-or-high-risk-primary-or-secondary-myelofibrosis2023-07-21T14:19Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-the-effect-of-resmetirom-on-liver-related-outcomes-in-patients-with-well-compensated-child-pugh-a-non-alcoholic-steatohepatitis-nash-cirrhosis-maestro-nash2024-07-30T19:30Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-double-blind-placebo-controlled-study-evaluating-the-safety-and-efficacy-of-magrolimab-versus-placebo-in-combination-with-venetoclax-and-azacitidine-in-newly-diagnosed-previously-untreated-patients-with-acute2023-08-03T18:05Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-feasibility-trial-of-tazemetostat-plus-car-t-cell-therapy-in-b-cell-lymphomas2023-08-09T14:24Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-single-arm-phase-ii-study-with-safety-run-in-of-peptide-receptor-radionuclide-therapy-prrt-in-combination-with-immunotherapy-for-patients-with-merkel-cell-cancer-hcrn-mcc20-443-iprrt-study2023-08-16T14:45Znever https://jcto.weill.cornell.edu/open_clinical_trials/in-vivo-evaluation-of-lymph-nodes-using-quantitative-ultrasound2023-09-12T14:44Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-dose-escalation-and-expansion-study-of-tac-001-in-patients-with-select-advanced-or-metastatic-solid-tumors2025-04-23T14:58Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iiiii-trial-of-nivolumab-ipilimumab-and-gm-csf-in-patients-with-advanced-melanoma2023-09-12T18:06Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-multicenter-study-of-incb123667-as-monotherapy-in-participants-with-selected-advanced-solid-tumors2023-10-17T19:22Znever https://jcto.weill.cornell.edu/open_clinical_trials/preserving-erectile-function-by-quantifying-the-nerve-sparing-step-of-the-robotic-prostatectomy-02023-09-13T14:48Znever https://jcto.weill.cornell.edu/open_clinical_trials/art-therapy-in-a-hematologyoncologybone-marrow-transplant-clinics-for-pediatric-adolescent-and-young-adult-patients-a-pilot-multi-site-mixed-methods-observational-study2023-09-13T15:03Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b2a-study-of-gemcitabine-and-nab-paclitaxel-in-combination-with-avutometinib-vs-6766-and-defactinib-in-patients-with-previously-untreated-metastatic-adenocarcinoma-of-the-pancreas2023-09-19T16:16Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iib-open-label-randomized-study-of-nab-paclitaxel-and-gemcitabine-plusminus-vcn-01-in-patients-with-metastatic-pancreatic-cancer2023-09-19T16:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/pilot-study-of-psma-trt-re-treatment-utilizing-225ac-j5912023-09-19T16:25Znever https://jcto.weill.cornell.edu/open_clinical_trials/seeded-cells-on-matrix-plug-treating-crohn’s-perianal-fistulas-stomp-ii2023-09-25T20:37Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ib-study-of-nivolumab-in-patients-with-autoimmune-disorders-and-advanced-malignancies-aim-nivo2024-05-24T14:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/apec1621c-nci-cog-pediatric-match-molecular-analysis-for-therapy-choice-screening-protocol2023-10-02T20:35Znever https://jcto.weill.cornell.edu/open_clinical_trials/first-in-human-phase-12-trial-of-eli-002-7p-immunotherapy-as-treatment-for-subjects-with-kirsten-rat-sarcoma-krasneuroblastoma-ras-viral-oncogene-homolog-nras-mutated-pancreatic-ductal-adenocarcinoma-pdac-and-other-solid-tumors2023-10-03T14:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-1-study-of-venetoclaxazacitidine-or-venetoclax-in-combination-with-ziftomenib-ko-539-or-standard-induction-cytarabinedaunorubicin-73-chemotherapy-in-combination-with-ziftomenib-for-the-treatment-of-patients-with-acute-myeloid2023-10-11T15:59Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-trial-of-inotuzumab-ozogamicin-ind133494-nsc-772518-for-newly-diagnosed-high-risk-b-all-risk-adapted-post-induction-therapy-for-high-risk-b-all-mixed-phenotype-acute-leukemia-and-disseminated-b-lly2023-10-17T15:42Znever https://jcto.weill.cornell.edu/open_clinical_trials/the-project-everychild-protocol-a-registry-eligibility-screening-biology-and-outcome-study-02023-10-17T15:47Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-of-ipatasertib-in-combination-with-pembrolizumab-for-first-line-treatment-of-recurrent-or-metastatic-squamous-cell-cancer-of-the-head-and-neck2023-11-06T14:25Znever https://jcto.weill.cornell.edu/open_clinical_trials/randomized-phase-2-study-of-daunorubicin-and-cytarabine-liposome-pomalidomide-versus-daunorubicin-and-cytarabine-liposome-in-newly-diagnosed-aml-with-mds-related-changes2023-11-03T14:22Znever https://jcto.weill.cornell.edu/open_clinical_trials/brain-18f-fes-petct-in-the-diagnosis-treatment-planning-and-response-assessment-of-brain-metastases-in-patients-with-estrogen-receptor-positive-breast-cancer2023-11-07T16:07Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2b-multicenter-randomized-double-blind-study-of-safety-and-efficacy-of-tak-755-radamts13-with-minimal-to-no-plasma-exchange-pex-in-the-treatment-of-immune-mediated-thrombotic-thrombocytopenic-purpura-ittp2023-11-07T16:23Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-safety-tolerability-and-efficacy-study-of-nc525-in-subjects-with-advanced-myeloid-neoplasms2023-11-07T16:30Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iia-randomized-double-blinded-clinical-trial-of-naproxen-or-aspirin-for-cancer-immune-interception-in-lynch-syndrome2023-11-17T16:24Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-clinical-study-of-aliya-pulsed-electric-fields-pef-delivered-prior-to-standard-of-care-treatment-for-advanced-cancer2024-04-02T19:10Znever https://jcto.weill.cornell.edu/open_clinical_trials/antenatal-anxiety-and-dyadic-immune-risk-adir-study2023-11-27T21:20Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-randomized-double-blind-placebo-controlled-phase-ii-study-to-investigate-the-efficacy-and-safety-of-cyp-001-in-combination-with-corticosteroids-vs-corticosteroids-alone-for-the-treatment-of-high-risk-acute-graft-versus2023-12-05T15:55Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-study-of-dato-dxd-with-or-without-durvalumab-versus-investigators-choice-of-therapy-in-patients-with-stage-i-iii-triple-negative-breast-cancer-without-pathological-complete-response-following-neoadjuvant-therapy-tropion-breast032023-12-05T17:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/rosuvastatin-efficacy-and-safety-for-cirrhosis-in-the-united-states-rescu-a-double-blind-randomized-placebo-controlled-phase-2-study2023-12-11T16:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-real-world-study-of-ecoin-for-urgency-urinary-incontinence-post-approval-evaluation-recipe2023-12-11T20:15Znever https://jcto.weill.cornell.edu/open_clinical_trials/register-dependent-variability-of-pitch-and-amplitude-control-in-singers2023-12-21T21:12Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-randomized-control-trial-of-triapine-plus-lutetium-lu-177-dotatate-versus-lutetium-lu-177-dotatate-alone-for-well-differentiated-somatostatin-receptor-positive-neuroendocrine-tumors2023-12-21T16:40Znever https://jcto.weill.cornell.edu/open_clinical_trials/inventiva-337hnas20011-nativ3-a-randomised-double-blind-placebo-controlled-multicentre-phase-3-study-evaluating-efficacy-and-safety-of-lanifibranor-followed-by-an-active-treatment-extension-in-adult-patients-with-non-cirrhotic-non2023-12-28T15:03Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-pragmatic-observational-study-of-biometrics-collected-by-wearable-technology-in-patients-with-liver-disease2024-07-22T14:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/multi-modal-neuroimaging-and-cognitive-assessment-of-females-with-multiple-sclerosis-across-different-stages-of-menopause2025-06-05T18:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/the-janus-rectal-cancer-trial-a-randomized-phase-ii-trial-testing-the-efficacy-of-triplet-versus-doublet-chemotherapy-to-achieve-clinical-complete-response-in-patients-with-locally-advanced-rectal-cancer2024-01-03T18:37Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-multicentre-integrated-phase-1-2-study-to-evaluate-the-safety-tolerability-radiation-dosimetry-and-anti-tumour-activity-of-lutetium-177lu-rhpsma-101-injection-in-men-with-metastatic-castrate-resistant-prostate-cancer2024-01-05T21:41Znever https://jcto.weill.cornell.edu/open_clinical_trials/pain-reduction-using-neurostimulation-prune-study2024-10-08T16:50Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/diet-and-meal-timing-in-patients-with-non-alcoholic-fatty-liver-disease-a-pilot-study2024-07-22T14:33Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/pilotfeasibility-study-of-pulmonary-nodules-and-coronary-calcification-screening-at-standard-computed-tomography-simulation-for-breast-cancer-radiotherapy-screening-from-ct-simulation-scts2024-01-17T17:05Znever https://jcto.weill.cornell.edu/open_clinical_trials/head-and-neck-patient-registry2024-01-17T17:14Znever https://jcto.weill.cornell.edu/open_clinical_trials/pelvic-fascia-sparing-radical-prostatectomy-trial-partial2024-01-23T16:35Znever https://jcto.weill.cornell.edu/open_clinical_trials/optimizing-surgical-decisions-in-young-adults-with-breast-cancer2024-01-29T15:38Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b-open-label-multi-center-dose-optimization-and-dose-expansion-study-to-assess-the-safety-and-efficacy-of-dfv890-in-adult-patients-with-myeloid-diseases2024-01-29T16:47Znever https://jcto.weill.cornell.edu/open_clinical_trials/prospective-evaluation-of-nivolumab-in-adjuvant-esophageal-carcinomagastroesophageal-junction-cancer-a-non-interventional-study-02024-01-29T17:13Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-phase-ii-multi-center-study-of-inflammation-modification-of-canakinumab-to-prevent-leukemic-progression-of-clonal-cytopenias-of-unknown-significance-ccus-impact-study2024-01-29T17:19Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-11b-dose-escalation-and-cohort-expansion-study-of-mgc018-in-combination-with-mgd019-in-participants-with-advanced-solid-tumors2024-05-24T15:01Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-trial-of-tazemetostat-plus-mosunetuzumab-in-untreated-follicular-lymphoma2024-02-07T15:56Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-multi-site-open-label-phase-ii-randomized-controlled-trial-to-compare-the-efficacy-of-ro7198457-versus-watchful-waiting-in-resected-stage-ii-high-risk-and-stage-iii-colorectal-cancer-patients-who-are-ctdna-positive-following2024-02-07T16:03Znever https://jcto.weill.cornell.edu/open_clinical_trials/randomized-phase-2-study-of-dkn-01-plus-folfirifolfox-and-bevacizumab-versus-folfirifolfox-and-bevacizumab-as-second-line-treatment-of-advanced-colorectal-cancer-defiance2024-02-09T16:49Znever https://jcto.weill.cornell.edu/open_clinical_trials/anhl2121-phase-2-study-of-tovorafenib-day101-in-relapsed-and-refractory-langerhans-cell-histiocytosis2024-02-08T20:08Znever https://jcto.weill.cornell.edu/open_clinical_trials/long-term-follow-up-protocol-for-participants-treated-with-gene-modified-t-cells2024-02-21T20:52Znever https://jcto.weill.cornell.edu/open_clinical_trials/randomized-phase-iii-trial-of-mfolfirinox-nivolumab-vs-folfox-nivolumab-for-first-line-treatment-of-metastatic-her2-negative-gastroesophageal-adenocarcinoma2024-02-26T20:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/rebyota-for-the-prevention-of-recurrence-of-clostridioides-difficile-infection-cdi-in-adult-patients-an-observational-study-study-summary2024-07-22T14:33Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/molecular-pathogenesis-of-plasma-cell-disorder2024-03-11T14:16Znever https://jcto.weill.cornell.edu/open_clinical_trials/platform-study-of-immunotherapy-combinations-in-colorectal-cancer-liver-metastases2024-03-11T15:51Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-study-of-parg-inhibitor-ide161-in-participants-with-advanced-solid-tumors2024-03-11T15:57Znever https://jcto.weill.cornell.edu/open_clinical_trials/evaluation-of-talazoparib-a-parp-inhibitor-in-patients-with-somatic-brca-mutant-metastatic-breast-cancer-genotyping-based-clinical-trial2024-03-11T16:01Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-pragmatic-randomized-phase-iii-trial-evaluating-total-ablative-therapy-for-patients-with-limited-metastatic-colorectal-cancer-evaluating-radiation-ablation-and-surgery-erasur2024-03-15T13:17Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-study-of-m3814-and-avelumab-in-combination-with-hypofractionated-radiation-in-patients-with-advancedmetastatic-solid-tumors-and-hepatobiliary-malignancies2024-03-15T13:16Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-trial-investigating-blinatumomab-in-combination-with-chemotherapy-in-patients-with-newly-diagnosed-standard-risk-or-down-syndrome-b-lymphoblastic-leukemia-b-all-and-the-treatment-of-patients-with-localized-b-lymphoblastic2024-03-15T13:26Znever https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-multi-center-pivotal-efficacy-and-safety-study-evaluating-the-endobarrier-system-for-glycemic-improvement-in-patients-with-inadequately-controlled-type-2-diabetes-and-obesity2024-07-22T14:28Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-dose-escalation-and-cohort-expansion-clinical-trial-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-arv-766-monotherapy-and-in-combination-with-abiraterone-in-patients-with-metastatic2024-04-02T14:45Znever https://jcto.weill.cornell.edu/open_clinical_trials/an-adaptive-phase-3-randomized-open-label-multicenter-study-to-compare-the-efficacy-and-safety-of-axicabtagene-ciloleucel-versus-standard-of-care-therapy-as-first-line-therapy-in-subjects-with-high-risk-large-b-cell-lymphoma-zuma-232024-04-02T14:50Znever https://jcto.weill.cornell.edu/open_clinical_trials/targeting-cd38-with-daratumumab-in-primary-antiphospholipid-syndrome-a-phase-1b-dose-escalation-safety-trial2024-04-02T14:54Znever https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-suratadenoturev-obp-301-in-combination-with-pembrolizumab-in-immunotherapy-refractory-esophagogastric-adenocarcinoma2024-04-02T19:29Znever https://jcto.weill.cornell.edu/open_clinical_trials/comparison-of-anti-coagulation-and-anti-platelet-therapies-for-intracranial-vascular-atherostenosis-captiva2024-04-17T17:18Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-double-blind-parallel-group-placebo-controlled-study-to-demonstrate-the-efficacy-and-safety-of-milvexian-an-oral-factor-xia-inhibitor-for-stroke-prevention-after-an-acute-ischemic-stroke-or-high-risk-tia-librexia2024-04-17T20:12Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-multicentre-phase-ii-open-label-study-to-evaluate-the-efficacy-of-acalabrutinib-in-combination-with-venetoclax-and-rituximab-in-participants-with-treatment-naïve-mantle-cell-lymphoma-traverse2024-04-23T13:48Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-multicenter-dose-escalation-and-expansion-study-of-kb707-in-subjects-with-locally-advanced-or-metastatic-solid-tumor-malignancies2024-04-23T13:54Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-randomized-study-of-maintenance-nivolumab-versus-observation-in-patients-with-locally-advanced-intermediate-risk-hpv-positive-opscc2024-04-23T14:07Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-iii-trial-of-pre-operative-compared-to-post-operative-stereotactic-radiosurgery-in-patients-with-resectable-brain-metastases2024-08-14T18:55Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-pilot-study-to-evaluate-feasibility-of-intraoperative-gamma-probe-tracing-of-meningioma-using-cu64-dotatate2024-04-30T20:44Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/assessment-of-placental-perfusion-and-oxygenation-using-novel-mri-approaches2024-05-08T17:11Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/technical-development-for-fetal-and-neonatal-mri2024-05-08T18:03Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-open-label-randomised-study-of-datopotamab-deruxtecan-versus-investigator’s-choice-of-chemotherapy-in-patients-who-are-not-candidates-for-pd-1pd-l1-inhibitor-therapy-in-first-line-locally-recurrent-inoperable-or-metastatic2024-05-14T14:27Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-i-multicenter-open-label-first-in-human-study-of-orm-5029-in-subjects-with-her2-expressing-advanced-solid-tumors2024-05-14T14:32Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-phase-ii-multi-center-study-of-inflammation-modification-of-canakinumab-to-prevent-leukemic-progression-of-clonal-cytopenias-of-unknown-significance-ccus-impact-study-02024-05-14T14:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-two-tiered-phase-ii-rule-based-intra-patient-dose-escalation-study-to-investigate-safety-and-feasibility-of-vactosertib-tew-7197-for-the-treatment-of-anemic-patients-with-philadelphia-chromosome-negative-myeloproliferative-neoplasms2024-05-14T17:01Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-multicenter-phase-3-study-to-evaluate-the-safety-tolerability-and-efficacy-of-xen1101-as-adjunctive-therapy-in-focal-onset-seizures2024-05-14T15:29Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/do-more-feel-better-lay-delivered-behavioral-activation-in-senior-centers2024-05-17T19:20Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/whole-body-hyperthermia-for-mood-and-anxiety-disorders2024-05-24T15:24Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-52-week-double-blind-placebo-controlled-randomized-phase-3-study-intended-to-determine-the-effects-of-seladelpar-on-normalization-of-alkaline-phosphatase-levels-in-subjects-with-primary-biliary-cholangitis-pbc-and-an-incomplete2024-07-22T14:26Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/multicenter-randomized-phase-ii-trial-of-neoadjuvant-radioimmunotherapy-versus-chemoimmunotherapy-in-patients-with-clinical-stages-ib-iii-n2-non-small-cell-lung-cancer2025-01-15T16:51Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-of-cemiplimab-anti-pd-1-antibody-in-combination-with-bnt116-fixvac-lung-versus-cemiplimab-monotherapy-in-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc-with-tumors-expressing-pd-l1-≥502024-06-17T17:58Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-first‑in‑human-study-evaluating-safety-pharmacokinetics-and-efficacy-of-abbv‑787-in-adult-subjects-with-acute-myeloid-leukemia-aml2024-06-17T19:32Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-extension-study-to-evaluate-the-long-term-safety-of-rusfertide-ptg-300-in-subjects-with-polycythemia-vera2024-06-17T19:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-multicenter-open-label-randomized-dose-ranging-and-expansion-study-of-the-combination-of-gilteritinib-venetoclax-azacitidine-in-patients-with-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-not-eligible-for-intensive2024-06-25T17:12Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/post-transplant-nash-protocol-to-assess-the-development-of-metabolic-comorbidities-and-disease-recurrence-in-those-transplanted-for-nash-cirrhosis2024-06-25T14:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-ibiii-open-label-randomised-study-of-capivasertib-plus-cdk46-inhibitors-fulvestrant-vs-cdk46-inhibitors-fulvestrant-in-hr-human-epidermal-growth-factor-receptor-2-negative-locally-advanced-unresectable-or-metastatic-breast2024-07-01T17:54Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-modular-phase-iii-open-label-multicenter-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-activity-of-azd9829-as-monotherapy-or-in-combination-in-patients-with-cd123-positive-hematological2024-07-01T18:03Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/assessment-of-colonic-oxygenation-utilizing-intraoxtm2025-07-09T15:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-prospective-multicenter-randomized-clinical-investigation-evaluating-gatt-patch-for-hemostasis-during-minimally-invasive-liver-and-gallbladder-surgery2024-07-11T15:24Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/comparison-of-surgery-and-medicine-on-the-impact-of-diverticulitis-cosmid-trial-cosmid2025-07-09T15:44Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-safety-and-effectiveness-prospective-blinded-clinical-study-to-validate-xbar-system-as-monitoring-tool-for-anastomotic-leaks-detection2025-07-09T15:32Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-single-center-investigator-initiated-phase-1b-trial-of-e-cel-uvec-as-an-adjunct-cell-therapy-for-treatment-of-anal-fistulas2025-07-09T15:42Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1phase-2-trial-to-evaluate-safety-immunogenicity-and-psa-response-of-vtp-850-prostate-cancer-immunotherapeutic-in-men-with-biochemical-recurrence-after-definitive-local-therapy-for-prostate-cancer2024-08-23T18:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-selinexor-monotherapy-in-subjects-with-jak-inhibitor-naïve-myelofibrosis-and-moderate-thrombocytopenia2024-07-26T18:13Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-active-controlled-open-label-multicenter-study-to-compare-the-efficacy-safety-of-mk-2870-monotherapy-vs-treatment-of-physician’s-choice-in-endometrial-cancer-participants-who-received-prior-platinum-based-chemo2025-12-16T21:10Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/the-pain-identification-and-communication-toolkit-a-training-program-to-support-family-caregivers-of-persons-with-alzheimer’s-disease-and-related-dementias2024-08-13T14:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-multicenter-extension-study-for-patients-previously-enrolled-in-studies-with-pelabresib2024-08-13T14:57Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-multicenter-randomized-platform-study-of-p19-inhibition-of-the-il-23-pathway-to-establish-efficacy-in-pediatric-crohn’s-disease-macaroni-232025-08-04T15:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-multicenter-dose-escalation-study-of-sgr-1505-as-monotherapy-in-subjects-with-mature-b-cell-malignancies2024-08-14T13:14Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-double-blind-placebo-controlled-study-evaluating-the-safety-and-efficacy-of-efruxifermin-in-subjects-with-non-cirrhotic-nonalcoholic-steatohepatitis-nash-and-fibrosis2024-08-13T18:10Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/expanded-access-study-for-the-treatment-of-patients-with-commercially-out-of-specification-brexucabtagene-autoleucel2024-08-27T18:25Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-multicenter-study-of-janx007-in-subjects-with-metastatic-castration-resistant-prostate-cancer2024-08-29T17:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-two-stage-randomized-controlled-trial-comparing-the-safety-and-efficacy-of-iltamiocel-with-placebo-in-the-treatment-of-female-participants-with-chronic-fecal-incontinence-and-a-history-of-obstetric-anal-sphincter-injury-dignifi2025-07-09T15:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-single-center-investigator-initiated-phase-1b-trial-of-e-cel-uvec-cell-therapy-for-the-treatment-of-chronic-anal-fissure2025-07-09T15:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-study-to-evaluate-the-safety-and-effectiveness-of-the-standard-of-care-diversion-diverting-ileostomy-following-low-anterior-resection2025-07-09T15:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/percutaneous-deep-vein-arterialization-for-the-treatment-of-late-stage-chronic-limb-threatening-ischemia-the-promise-iii-trial2024-09-04T13:59Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-2-study-of-daratumumab-selinexor-velcade-dexamethasone-dara-svd-for-high-risk-newly-diagnosed-multiple-myeloma2024-09-05T19:21Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/technology-driven-enhancement-to-engage-connect-tree-connect2025-06-05T18:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/local-methotrexate-injections-for-the-treatment-of-nail-psoriasis2024-09-18T16:15Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/expanded-access-study-for-the-treatment-of-patients-with-commercially-out-of-specification-axicabtagene-ciloleucel2024-10-02T13:39Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-open-label-randomised-study-to-assess-the-efficacy-and-safety-of-camizestrant-azd9833-a-next-generation-oral-selective-estrogen-receptor-degrader-versus-standard-endocrine-therapy-aromatase-inhibitor-or-tamoxifen-as2024-10-02T13:44Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-open-label-safety-and-tolerability-study-of-incb057643-in-participants-with-myelofibrosis-and-other-advanced-myeloid-neoplasms2024-10-02T14:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-open-label-randomised-study-of-neoadjuvant-datopotamab-deruxtecan-dato-dxd-plus-durvalumab-followed-by-adjuvant-durvalumab-with-or-without-chemotherapy-versus-neoadjuvant-pembrolizumab-plus-chemotherapy-followed-by2024-10-02T14:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-adjuvant-trial-evaluating-the-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-plus-endocrine-therapy-in-premenopausal-patients-with-pn0-1-er-positiveher2-negative-breast-cancer-and-an-oncotype-recurrence2025-12-16T21:09Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-ii-trial-of-consolidation-therapy-following-cd19-car-t-cell-treatment-for-relapsedrefractory-large-b-cell-lymphoma-or-grade-iiib-follicular-lymphoma2024-10-29T13:44Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/radioembolization-oncology-trial-utilizing-transarterial-eye90-route-90-for-the-treatment-of-hepatocellular-carcinoma-hcc2024-11-01T13:06Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-multicenter-open-label-study-of-cb-012-a-crispr-edited-allogeneic-anti-cll-1-car-t-cell-therapy-in-patients-with-relapsedrefractory-acute-myeloid-leukemia2024-11-26T18:07Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iv-post-authorization-safety-study-to-investigate-the-long-term-safety-of-lutetium-177lu-vipivotide-tetraxetan-in-adult-participants-with-prostate-cancer2024-11-26T18:11Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b2-study-of-bgb-11417-as-monotherapy-and-in-various-combinations-with-dexamethasone-plus-carfilzomib-dexamethasone-plus-daratumumab-and-dexamethasone-plus-pomalidomide-in-multiple-myeloma2024-11-26T18:19Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/the-impact-of-biosynthetic-mesh-on-paraesophageal-hernia-repair-in-robotic-anti-reflux-surgery-a-multi-institutional-randomized-trial2024-12-12T15:49Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/real-world-evaluation-of-the-histosonics-edison-system-for-treatment-of-liver-tumors-across-multidisciplinary-users2024-12-12T15:56Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-study-of-lmn-201-for-prevention-of-c-difficile-infection-recurrence-repreve2024-12-13T20:08Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-double-blind-placebo-controlled-study-evaluating-the-safety-and-efficacy-of-efruxifermin-in-subjects-with-compensated-cirrhosis-due-to-nonalcoholic-steatohepatitis-nashmetabolic-dysfunction-associated2024-12-13T20:17Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/comprehensive-assessment-of-cancer-theranostics-response-investigating-the-intent-to-change-treatment-decisions-based-on-traqinform-theranostics2024-12-13T20:24Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/habit-awareness-device-for-treatment-of-onychophagia2024-12-13T20:50Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/clinical-effect-of-caffeine-consumption-in-patients-taking-oral-terbinafine2024-12-17T17:09Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/implantation-mycoses-in-immunocompromised-patients-a-retrospective-review-of-disease-course-and-treatment-efficacy2025-01-14T17:36Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-3-trial-of-continuous-vs-intermittent-maintenance-therapy-with-zanubrutinib-as-upfront-treatment-in-older-patients-with-mantle-cell-lymphoma-intercon2025-01-16T21:58Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/qsm-for-detection-of-hemorrhaging-cysts-and-risk-stratification-in-adpkd2026-01-08T16:03Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-open-label-phase-3-study-to-evaluate-the-pharmacokinetics-safety-and-immunogenicity-of-vedolizumab-subcutaneous-in-pediatric-subjects-with-moderately-to-severely-active-ulcerative-colitis-or-crohn’s-disease2025-08-04T15:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-prospective-multicenter-single-arm-non-randomized-clinical-study-designed-to-evaluate-the-safety-and-effectiveness-of-the-citadel-embolization-device2025-03-13T17:19Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/efficacy-of-luspatercept-in-clonal-cytopenias-of-uncertain-significance2025-02-27T15:56Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-open-label-multicentric-two-arm-pivotal-trial-of-sonocloud-9-combined-with-carboplatin-cbdca-vs-standard-of-care-lomustine-ccnu-or-temozolomide-tmz-in-patients-undergoing-planned-resection-for-first-recurrence2025-02-27T16:20Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-ib-trial-of-erdafitinib-combined-with-enfortumab-vedotin-following-platinum-and-pd1l1-inhibitors-for-metastatic-urothelial-carcinoma-with-fgfr23-genetic-alterations2025-03-21T15:12Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherapy-in-patients-with-stage-4-non-small-cell-lung-cancer2025-03-26T14:18Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/elegance-drug-eluting-registry-real-world-treatment-of-lesions-in-the-peripheral-vasculature2025-03-31T14:38Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/esprit-btk-post-approval-study-pas2025-03-31T15:55Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/boomerang-pivotal-multicenter-trial-of-the-boomerang-catheter-for-percutaneous-deep-vein-arterialization-pdva2025-03-31T17:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/serranator-oct-understanding-the-mechanism-of-action-of-serration-angioplasty-by-serranator-versus-conventional-balloon-angioplasty-for-below-the-knee-btk-artery-disease-using-optical-coherence-tomography-oct2025-03-31T18:04Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-multicenter-randomized-open-label-study-comparing-the-efficacy-and-safety-of-glofitamab-in-combination-with-pola-r-chp-versus-pola-r-chp-in-previously-untreated-patients-with-large-b-cell-lymphoma2025-05-08T13:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-double-blind-placebo-controlled-program-to-evaluate-the-efficacy-and-safety-of-tulisokibart-in-participants-with-moderately-to-severely-active-crohn’s-disease2025-05-07T16:38Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-feasibility-clinical-trial-for-low-intensity-focused-ultrasound-neuromodulation-in-patients-with-opioid-use-disorder-oud-andor-other-substance-use-disorders-sud2025-04-23T15:20Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-3-randomized-double-blind-placebo-controlled-multicenter-study-of-cvn424-in-parkinsons-disease-patients-with-motor-complications2025-04-23T16:04Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-open-label-randomized-phase-2-study-of-venetoclax-and-azacitidine-plus-cusatuzumab-versus-venetoclax-and-azacitidine-alone-in-newly-diagnosed-aml-patients-who-are-not-candidates-for-intensive-therapy2025-04-25T13:51Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/evaluating-the-prevalence-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-during-pregnancy-and-its-influence-on-pregnancy-outcomes-and-postpartum-maternal-health2025-04-29T17:16Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/venetoclax-in-combination-with-astx727-an-all-oral-therapy-for-chronic-myelomonocytic-leukemia-and-other-mdsmpn-with-excess-blasts-victory-mdsmpn-a-randomized-phase-2-trial2025-05-22T17:43Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/nrg-gu013-the-phase-iii-high-five-trial-five-fraction-radiation-for-high-risk-prostate-cancer2026-03-19T18:20Zweekly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b2-open-label-master-protocol-study-of-btk-degrader-bgb-16673-in-combination-with-other-agents-in-patients-with-relapsed-or-refractory-b-cell-malignancies2025-07-02T15:27Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-multicentre-prospective-open-label-uncontrolled-phase-3-study-to-assess-the-efficacy-safety-and-pharmacokinetics-of-atenativ-in-patients-with-congenital-antithrombin-deficiency-undergoing-surgery-or-delivery2025-07-02T15:39Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/use-of-blood-tumor-tissue-and-tumor-infiltrating-lymphocyte-biospecimens-for-immune-cell-profiling-and-research2025-07-02T15:57Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/evaluation-of-the-safety-and-effectiveness-of-the-gore-tissue-reinforcement-for-breast-reconstruction-device-trbr-device-when-used-in-the-reinforcement-of-breast-reconstruction-gore-redefine-study-tbr-22-072025-07-03T14:06Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/modern-an-integrated-phase-23-and-phase-3-trial-of-mrd-based-optimization-of-adjuvant-therapy-in-urothelial-cancer2025-12-16T21:10Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-crossover-study-of-on-demand-prep-formulations-comparing-rectal-and-oral-tenofovir-based-prep-evaluating-extended-safety-acceptability-and-pharmacokineticspharmacodynamics2025-09-30T15:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3b-open-label-randomized-standard-of-care-control-arm-multicenter-superiority-study-evaluating-the-efficacy-safety-and-tolerability-of-injectable-cab-la-rpv-la-in-viremic-participants-living-with-hiv-1-crown2025-08-13T16:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/checking-in-the-role-of-sleep-in-cardiovascular-health-among-men-living-with-hiv2025-09-30T15:53Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-open-label-study-to-evaluate-the-efficacy-and-safety-of-tobevibartelebsiran-combination-therapy-in-participants-with-chronic-hdv-infection-eclipse-12025-08-19T15:14Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-prospective-multi-center-single-arm-study-of-endoscopic-ultrasound-guided-gastroenterostomy-with-lumen-apposing-metal-stent-for-gastric-outlet-obstruction-from-malignant-unresectable-disease2025-08-19T15:20Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-first-in-human-dose-escalation-and-dose-expansion-study-of-bhv-1510-previously-pbi-410-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-participants-with-advanced-solid-tumors2025-08-19T15:31Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-iii-study-of-rilvegostomig-in-combination-with-fluoropyrimidine-and-trastuzumab-deruxtecan-versus-trastuzumab-chemotherapy-and-pembrolizumab-for-the-first-line-treatment-of-her2-positive-gastric-cancer2025-08-21T17:49Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/genetic-developmental-and-epileptic-encephalopathy-natural-history-study-for-clinical-trial-readiness2025-09-09T17:24Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/alzheimers-network-for-treatment-and-diagnostics-alz-net2025-10-01T14:18Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-seamless-phase-2a-phase-2b-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-safety-and-efficacy-of-benfotiamine-in-patients-with-early-alzheimer’s-disease-benfo-team2025-10-01T14:17Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-ii-study-of-reparixin-in-patients-with-myelofibrosis-myeloproliferative-neoplasms-research-consortium-mpn-rc-1202025-09-30T15:14Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-multi-center-study-of-the-safety-tolerability-and-efficacy-of-gim-531-as-a-single-agent-and-in-combination-with-anti-pd-1-in-advanced-solid-tum2025-09-30T15:32Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-multicenter-randomized-double-blind-sham-controlled-parallel-group-phase-3-study-evaluating-the-efficacy-safety-and-tolerability-of-zorevunersen-stk-001-in-patients-with-dravet-syndrome2025-09-30T15:45Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-study-to-evaluate-the-efficacy-and-safety-of-pegozafermin-in-subjects-with-compensated-cirrhosis-due-to-metabolic-dysfunction-associated-steatohepatitis-mash2025-09-30T15:50Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/cold-snare-endoscopic-mucosal-resection-of-duodenal-adenomas-≥10-mm-a-prospective-cohort2025-09-30T16:05Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/access-to-high-quality-cancer-care-among-gastrointestinal-cancer-patients2025-10-03T18:40Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-global-randomized-open-label-multicenter-phase-2b3-trial-evaluating-bjt-778-vs-delayed-treatment-for-the-treatment-of-chronic-hepatitis-delta-infection-azure-12025-10-08T15:51Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phenylbutyrate-for-monogenetic-developmental-and-epileptic-encephalopathies2025-10-08T16:55Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/efficacy-of-the-coronary-sinus-reducer-in-patients-with-refractory-angina-ii-cosira-ii2025-10-15T17:30Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/endocardial-delivery-of-xc001-gene-therapy-for-refractory-angina-coronary-treatment-a-26-week-with-26-week-extension-phase-2b-randomized-multi-center-double-blind-sham-controlled-study-to-evaluate-efficacy-and-safety-the-exact-2-trial2025-10-15T17:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/the-magenta-elevate-high-risk-pci-pivotal-study-elevate-iii2025-10-15T17:48Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-open-label-study-to-compare-the-efficacy-and-safety-of-anitocabtagene-autoleucel-versus-standard-of-care-therapy-in-participants-with-relapsedrefractory-multiple-myeloma2025-11-07T16:45Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-open-label-randomised-study-of-osimertinib-with-or-without-dato-dxd-as-first-line-treatment-in-participants-with-epidermal-growth-factor-receptor-mutation-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer2025-11-07T17:09Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-of-blinatumomab-in-combination-with-chemotherapy-for-infants-with-newly-diagnosed-acute-lymphoblastic-leukemia-with-randomization-of-kmt2a-rearranged-patients-to-addition-of-venetoclax2025-11-07T21:25Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/expanded-access-treatment-protocol-for-bulevirtide2025-11-07T21:30Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iv-study-evaluating-the-safety-and-efficacy-of-neffy-or-intramuscular-adrenalin-in-patients-with-allergic-reactions-after-oral-food-challenge-or-allergen-immunotherapy-epi-r012025-11-11T19:17Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/phase-1-trial-of-ca-4948-in-combination-with-pembrolizumab-to-overcome-resistance-to-pd-1pd-l1-blockade-in-metastatic-urothelial-cancer2025-12-31T18:55Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-study-comparing-teclistamab-in-combination-with-daratumumab-sc-and-lenalidomide-tec-dr-and-talquetamab-in-combination-with-daratumumab-sc-and-lenalidomide-tal-dr-versus-daratumumab-sc-lenalidomide-and2025-12-08T17:30Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/prevalence-and-implications-of-cholestatic-gene-mutations-in-suspected-intrahepatic-cholestasis-of-pregnancy-among-a-diverse-us-cohort-a-prospective-study-in-a-diverse-health-setting-with-8000-annual-pregnancy-deliveries2025-12-31T18:42Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3b4-randomized-open-label-efficacy-assessor-blinded-study-to-evaluate-the-efficacy-and-safety-of-upadacitinib-for-the-treatment-of-adult-subjects-with-moderate-to-severe-atopic-dermatitis-ad-and-inadequate-response-to2025-12-08T17:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-12-open-label-platform-study-to-evaluate-safety-and-efficacy-of-etentamig-monotherapy-or-etentamig-combinations-in-subjects-with-multiple-myeloma2025-12-08T17:58Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/pilot-of-an-integrated-treatment-for-comorbid-ptsd-and-chronic-pain2025-12-16T15:41Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/assessment-of-attitudes-towards-psa-screening-and-decision-aids2025-12-16T15:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/gene-therapy-for-alpha-1-antitrypsin-deficiency2026-01-14T15:52Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/expanded-access-program-of-amtagvi-that-is-out-of-specification-for-commercial-release2025-12-16T16:06Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/nrg-bn013-phase-iii-trial-of-single-fraction-stereotactic-radiosurgery-srs-versus-fractionated-srs-fsrs-for-intact-brain-metastases2025-12-22T17:13Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a012301-lotam-a-randomized-phase-iii-clinical-trial-of-low-dose-tamoxifen-for-selected-patients-with-molecular-low-risk-early-stage-breast-cancer2025-12-31T18:56Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/tirzepatide’s-role-in-postmenopausal-hr-breast-cancer-survivors2025-12-23T16:35Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/experiences-of-individuals-who-have-participated-in-crystal-meth-anonymous-a-qualitative-study2025-12-31T18:47Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-double-blind-placebo-controlled-multicenter-phase-3-clinical-study-to-assess-efficacy-and-safety-of-ropeginterferon-alfa-2b-p1101-in-adult-patients-with-pre-fibroticearly-primary-myelofibrosis-or-overt-primary2026-01-08T15:46Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/bio89-100-131-a-phase-3-study-to-evaluate-the-efficacy-and-safety-of-pegozafermin-in-subjects-with-metabolic-dysfunction-associated-steatohepatitis-mash-and-fibrosis2026-01-08T15:42Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/an-international-pilot-study-of-chemotherapy-and-tyrosine-kinase-inhibitors-with-blinatumomab-in-patients-with-newly-diagnosed-philadelphia-chromosome-positive-or-abl-class-philadelphia-chromosome-like-b-cell-acute-lymphoblastic2026-01-14T15:11Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-phase-2-trial-of-astx727-iadademstat-in-acceleratedblast-phase-philadelphia-chromosome-negative-myeloproliferative-neoplasms-mpns2026-02-06T18:23Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-2-study-of-blinatumomab-nsc-765986-ind-147294-in-combination-with-nivolumab-nsc-748726-ind-147294-a-checkpoint-inhibitor-of-pd-1-in-b-all-patients-aged-1-to2026-01-14T15:34Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-trial-of-durvalumab-with-gemcitabine-and-cisplatin-as-neoadjuvant-therapy-for-high-risk-resectable-intrahepatic-cholangiocarcinoma2026-01-30T16:45Zyearly https://jcto.weill.cornell.edu/open_clinical_trials/a-multipart-open-label-single-arm-multicenter-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-ela026-in-participants-with-secondary-hemophagocytic-lymphohistiocytosis-shlh2026-02-06T19:17Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-open-label-study-to-investigate-the-efficacy-and-safety-of-itk-inhibitor-soquelitinib-versus-physician’s-choice-standard-of-care-treatment-selected-single-agent-in-participants-with-relapsedrefractory-peripheral-t2026-02-06T19:21Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1-study-of-bal0891-as-monotherapy-and-in-combination-with-chemotherapy-in-patients-with-advanced-solid-tumors-or-relapsed-or-refractory-acute-myeloid-leukemia2026-02-06T19:24Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b2-multicenter-randomized-open-label-study-to-evaluate-the-efficacy-and-safety-of-gsk5764227-alone-and-in-combination-in-participants-with-previously-treated-advanced-unresectable-or-metastatic-gastrointestinal-solid-tumors2026-02-06T19:43Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-randomized-study-evaluating-2-dose-regimens-of-dupilumab-in-children-≥6-months-of-age-weighing-≥5-to2026-02-09T17:55Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/pulmonary-segmentectomy-for-lung-cancer-a-real-world-international-registry-tsog-1082026-03-09T16:48Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/s2427-single-arm-phase-ii-study-of-bladder-preservation-with-immunoradiotherapy-after-a-clinically-meaningful-response-to-neoadjuvant-therapy-in-patients-with-muscle-invasive-bladder-cancer-bright2026-03-11T13:16Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3-randomized-open-label-study-of-belantamab-mafodotin-in-combination-with-lenalidomide-and-dexamethasone-versus-daratumumab-lenalidomide-and-dexamethasone-in-participants-with-newly-diagnosed-multiple-myeloma-who-are2026-03-11T20:30Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/development-of-rpbm-for-quantitative-assessment-of-myofascial-pain2026-03-17T15:42Zmonthly https://jcto.weill.cornell.edu/open_clinical_trials/prospective-randomized-study-of-the-kono-s-anastomosis-versus-the-side-to-side-functional-end-anastomosis-in-the-prevention-of-post-operative-recurrence-of-crohn’s-disease2026-03-30T17:50Zdaily https://jcto.weill.cornell.edu/open_clinical_trials/gs-us-567-6968-phase-12-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-antiviral-activity-of-gs-4321-in-healthy-participants-and-participants-with-chronic-hepatitis-delta2026-03-31T18:47Zhourly https://jcto.weill.cornell.edu/open_clinical_trials/fmt-and-other-gut-microbial-therapies-national-registry-acute-severe-and-fulminant-c-difficile-infection2026-03-31T18:52Zhourly https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-multisite-double-blinded-randomized-trial-of-bnt327-in-combination-with-chemotherapy-etoposidecarboplatin-compared-to-atezolizumab-in-combination-with-chemotherapy-in-participants-with-first-line-extensive-stage-small-cell2026-03-31T18:56Zhourly https://jcto.weill.cornell.edu/open_clinical_trials/phase-3-randomized-double-blind-placebo-controlled-studies-assessing-ziftomenib-in-combination-with-either-standard-of-care-nonintensive-venetoclaxazacitidine-or-intensive-73-therapy-in-patients-with-untreated-npm1-mutated-or-kmt2a2026-03-31T19:01Zhourly https://jcto.weill.cornell.edu/investigators2021-10-11T17:50Znever https://jcto.weill.cornell.edu/patients2018-11-29T15:42Znever https://jcto.weill.cornell.edu/patients/what-is-a-clinical-trial2022-04-11T17:20Znever https://jcto.weill.cornell.edu/node/342014-08-01T14:15Znever https://jcto.weill.cornell.edu/collaborators2018-11-29T17:15Znever https://jcto.weill.cornell.edu/node/432014-05-13T15:05Znever https://jcto.weill.cornell.edu/node/442014-05-13T16:46Znever https://jcto.weill.cornell.edu/node/452014-11-25T19:49Znever https://jcto.weill.cornell.edu/error/page-not-found2014-01-28T20:08Znever https://jcto.weill.cornell.edu/about/jcto-contacts2025-12-11T17:01Zyearly https://jcto.weill.cornell.edu/about/acknowledgements2015-09-22T18:09Znever https://jcto.weill.cornell.edu/node/892014-09-04T22:01Znever